Aqib Chaudhry
Family Medicine · North Attleboro, MANPI 1144758301
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. 2023 is the largest year on record at $581, more than ten times the $18 reported in 2020.
Across 48 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$207
- Daiichi Sankyo Inc.$104
- Novo Nordisk$85
- Otsuka America Pharmaceutical, Inc.$59
- Boehringer Ingelheim$56
- Pfizer$52
- plus $403 from 15 others
What the payments were for
- Food & beverage$965100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $207 |
| Daiichi Sankyo Inc. | 4 | $104 |
| Novo Nordisk | 5 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Boehringer Ingelheim | 2 | $56 |
| Pfizer | 3 | $52 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Lilly USA, LLC | 2 | $40 |
| Johnson & Johnson | 2 | $39 |
| Philips North America LLC | 2 | $38 |
| Amgen | 2 | $36 |
| GSK | 1 | $32 |
| Dexcom, Inc. | 1 | $23 |
| Harmony Biosciences LLC | 1 | $23 |
| Inogen, Inc. | 1 | $22 |
| Seqirus USA Inc | 1 | $20 |
| Exact Sciences | 1 | $20 |
| Novartis | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Sanofi | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
How this compares
$965 in reported general payments places this provider in the 85th percentile of 1,049 family medicine providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $11,042 |
| Omeprazole | 26 | $261 |
| Atorvastatin Calcium | 31 | $255 |
| Losartan Potassium | 29 | $244 |
| Levothyroxine Sodium | 32 | $189 |
| Metformin Hcl | 20 | $160 |
| Fluticasone Propionate | 15 | $151 |
| Pantoprazole Sodium | 11 | $138 |
| Trazodone Hcl | 25 | $127 |
| Simvastatin | 11 | $124 |
| Tamsulosin Hcl | 16 | $112 |
| Donepezil Hcl | 17 | $110 |
| Amlodipine Besylate | 18 | $104 |
| Gabapentin | 15 | $103 |
| Rosuvastatin Calcium | 11 | $97 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $52 | $11,04217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,049 family medicine providers in Massachusetts.
Other family medicine in North Attleboro
- Lisa BowieNorth Attleboro$4K
- Larry CulpepperBoston$109K
- Jennifer WeylerWorcester$105K
- Megan McCoyFramingham$75K
- Kristina GraceyWorcester$73K
- Suzanne MitchellBoston$69K
- John GrievesonLowell$24K
- James SalemisRoslindale$24K
- David FarzanLawrence$23K
- Julie JohnstonLawrence$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.